Optic pathway glioma volume predicts retinal axon degeneration in neurofibromatosis type 1
- PMID: 27815398
- PMCID: PMC5177678
- DOI: 10.1212/WNL.0000000000003402
Optic pathway glioma volume predicts retinal axon degeneration in neurofibromatosis type 1
Abstract
Objective: To determine whether tumor size is associated with retinal nerve fiber layer (RNFL) thickness, a measure of axonal degeneration and an established biomarker of visual impairment in children with optic pathway gliomas (OPGs) secondary to neurofibromatosis type 1 (NF1).
Methods: Children with NF1-OPGs involving the optic nerve (extension into the chiasm and tracts permitted) who underwent both volumetric MRI analysis and optical coherence tomography (OCT) within 2 weeks of each other were included. Volumetric measurement of the entire anterior visual pathway (AVP; optic nerve, chiasm, and tract) was performed using high-resolution T1-weighted MRI. OCT measured the average RNFL thickness around the optic nerve. Linear regression models evaluated the relationship between RNFL thickness and AVP dimensions and volume.
Results: Thirty-eight participants contributed 55 study eyes. The mean age was 5.78 years. Twenty-two participants (58%) were female. RNFL thickness had a significant negative relationship to total AVP volume and total brain volume (p < 0.05, all comparisons). For every 1 mL increase in AVP volume, RNFL thickness declined by approximately 5 microns. A greater AVP volume of OPGs involving the optic nerve and chiasm, but not the tracts, was independently associated with a lower RNFL thickness (p < 0.05). All participants with an optic chiasm volume >1.3 mL demonstrated axonal damage (i.e., RNFL thickness <80 microns).
Conclusions: Greater OPG and AVP volume predicts axonal degeneration, a biomarker of vision loss, in children with NF1-OPGs. MRI volumetric measures may help stratify the risk of visual loss from NF1-OPGs.
© 2016 American Academy of Neurology.
Comment in
-
Predicting which NF1 optic pathway gliomas will require treatment.Neurology. 2016 Dec 6;87(23):2389-2390. doi: 10.1212/WNL.0000000000003413. Epub 2016 Nov 4. Neurology. 2016. PMID: 27815404 No abstract available.
References
-
- Avery RA, Fisher MJ, Liu GT. Optic pathway gliomas. J Neuroophthalmol 2011;31:269–278. - PubMed
-
- Campagna M, Opocher E, Viscardi E, et al. . Optic pathway glioma: long-term visual outcome in children without neurofibromatosis type-1. Pediatr Blood Cancer 2010;55:1083–1088. - PubMed
-
- Shofty B, Ben-Sira L, Freedman S, et al. . Visual outcome following chemotherapy for progressive optic pathway gliomas. Pediatr Blood Cancer 2011;57:481–485. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous